Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GALBRIELA safely and effectively. See full prescribing information for GALBRIELA. GALBRIELATM (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets), for oral use Initial U.S. Approval: 1974
Medication labelWhy this: Advisory · dailymed-prescription
Galbriela (norethindrone and ethinyl estradiol chewable tablet and ferrous fumarate chewable tablet) is indicated for use by women to prevent pregnancy. The efficacy of Galbriela in women with a body mass index (BMI) of > 35 kg/m2 has not been evaluated.
- generic_name
- norethindrone and ethinyl estradiol and ferrous fumarate
- brand_name
- norethindrone and ethinyl estradiol, ferrous fumarate
- product_names
- norethindrone and ethinyl estradiol and ferrous fumarate, norethindrone and ethinyl estradiol, ferrous fumarate
- ndc
- 70700-306, 70700-306-84, 70700-306-85, 70700-843, 70700-844
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en